Autres langues Hyphens Pharma International Limited

Actions

1J5

SG1EE4000006

Marché Fermé - Singapore S.E. Autres places de cotation 05:25:03 19/04/2024			Varia. 5j.	Varia. 1 janv.
0,27 ^SGD	-1,82 %		0,00 %	-5,26 %

09/04	Le bénéfice attribuable de Hyphens Pharma diminue en 2023	MT
15/03	HYPHENS PHARMA INTERNATIONAL LIMITED : CGS-CIMB à l'achat	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Hyphens Pharma’s Attributable Profit Narrows in 2023	09/04
Hyphens Pharma International Limited Proposes Final Tax Exempt (One-Tier) Dividend	09/04
Hyphens Pharma Buys Back Shares	03/04
Hyphens Pharma licenses Wynzora Cream for ASEAN countries from MC2 Therapeutics	13/03
MC2 Therapeutics Announces License, Supply and Commercialization Agreement for Wynzora Cream in ASEAN Countries	13/03
Hyphens Pharma Obtains License to MC2's Psoriasis Cream	13/03
Hyphens Pharma International Limited Signs Exclusive Distribution Agreement with Cooper Pharma, S.A	29/02
Hyphens Pharma International Limited Reports Earnings Results for the Full Year Ended December 31, 2023	27/02
Hyphens Pharma Strikes Distribution Deal With 7-Eleven Singapore	13/02
Hyphens Pharma Partners 7-Eleven to Offer Ocean Health Supplements in Singapore	06/02
Hyphens Pharma International Grants Nearly 6 Million Shares Under Performance Share Plan	11/12
Hyphens Pharma International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Hyphens Pharma Unit Completes Purchase of First Tranche of Remaining Ardence Pharma Stake	09/11
Hyphens Pharma to Acquire Remaining 58% Stake in Ardence Pharma	18/10/23
Hyphens Pharma Unit to Distribute Daewoong Pharmaceutical's Nabota Botox in Malaysia	30/08/23
Hyphens Pharma International Limited Announces Special Interim Tax Exempt (One-Tier) Dividend for the Financial Year Ending 31 December 2023, Paid on 31 August 2023	10/08/23
Hyphens Pharma International Limited Reports Earnings Results for the Half Year Ended June 30, 2023	10/08/23
Hyphens Pharma Names CFO	05/06/23
Hyphens Pharma International Limited Appoints Zhang Yufan as Chief Financial Officer	05/06/23
Singapore Shares Return to Green; Hyphens Pharma Rises 5% on Deal to Develop Sedation Drug in Singapore	18/05/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Hyphens Pharma International Limited

Actions

1J5

SG1EE4000006

Autres langues

Filtres